Garipalli Vivek 4

4 · CLOVER HEALTH INVESTMENTS, CORP. /DE · Filed Jan 9, 2026

Form 4

Period: 2026-01-07

Director10% Owner

Transactions

Exercise/Conversion
Class A Common Stock
2026-01-07+1,655,949→ 3,512,196 total
Tax Payment
Class A Common Stock
2026-01-07$2.59/sh−1,655,949$4,288,908→ 1,856,247 total
Exercise/Conversion
Restricted Stock Unit
2026-01-07−3,342,699→ 0 total
→ Class B Common Stock (3,342,699 underlying)
Exercise/Conversion
Class B Common Stock
2026-01-07+3,342,699→ 10,247,042 total
→ Class A Common Stock (3,342,699 underlying)
Exercise/Conversion
Class B Common Stock
2026-01-07−1,655,949→ 8,591,093 total
→ Class A Common Stock (1,655,949 underlying)

Holdings

Class B Common Stock
(indirect: By LLC)
→ Class A Common Stock (75,694,143 underlying)
72,084,543
Class B Common Stock
(indirect: By LLC)
→ Class A Common Stock (11,500,000 underlying)
11,500,000

Footnotes (4)

[F1]The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.
[F2]On January 7, 2026, the final 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,686,750 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,655,949 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.
[F3]Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vested in equal installments on the first five anniversaries of January 7, 2021.
[F4]The Reporting Person serves as the sole manager of each of NJ Healthcare Investments, LLC and Caesar Clover, LLC.

Documents

1 file